143 related articles for article (PubMed ID: 33784906)
1. In silico guided design of non-covalent inhibitors of DprE1: synthesis and biological evaluation.
Verma H; Choudhary S; Kumar M; Silakari O
SAR QSAR Environ Res; 2021 Apr; 32(4):333-352. PubMed ID: 33784906
[TBL] [Abstract][Full Text] [Related]
2. Virtual Screening of Small Molecular Inhibitors against DprE1.
Zhang G; Guo S; Cui H; Qi J
Molecules; 2018 Feb; 23(3):. PubMed ID: 29495447
[TBL] [Abstract][Full Text] [Related]
3. Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies.
Bhutani I; Loharch S; Gupta P; Madathil R; Parkesh R
PLoS One; 2015; 10(3):e0119771. PubMed ID: 25789990
[TBL] [Abstract][Full Text] [Related]
4. Structure based pharmacophore modelling approach for the design of azaindole derivatives as DprE1 inhibitors for tuberculosis.
Kb S; Kumari A; Shetty D; Fernandes E; Dv C; Jays J; Murahari M
J Mol Graph Model; 2020 Dec; 101():107718. PubMed ID: 32949960
[TBL] [Abstract][Full Text] [Related]
5. Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.
Foo CS; Lechartier B; Kolly GS; Boy-Röttger S; Neres J; Rybniker J; Lupien A; Sala C; Piton J; Cole ST
Antimicrob Agents Chemother; 2016 Nov; 60(11):6451-6459. PubMed ID: 27527085
[TBL] [Abstract][Full Text] [Related]
6. Computer-assisted discovery of safe and effective DprE1/ aaRSs Inhibitors against TB utilizing Drug Repurposing approach.
Imran M; Abida ; Alotaibi NM; Thabet HK; Alruwaili JA; Asdaq SMB; Eltaib L; Kamal M; Alshammari ABH; Alshammari AMA; Alshehri A
J Infect Public Health; 2023 Apr; 16(4):554-572. PubMed ID: 36812878
[TBL] [Abstract][Full Text] [Related]
7. Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides.
Chikhale R; Menghani S; Babu R; Bansode R; Bhargavi G; Karodia N; Rajasekharan MV; Paradkar A; Khedekar P
Eur J Med Chem; 2015; 96():30-46. PubMed ID: 25874329
[TBL] [Abstract][Full Text] [Related]
8. Identification of hydantoin based Decaprenylphosphoryl-β-D-Ribose Oxidase (DprE1) inhibitors as antimycobacterial agents using computational tools.
Mali SN; Pandey A; Bhandare RR; Shaik AB
Sci Rep; 2022 Sep; 12(1):16368. PubMed ID: 36180452
[TBL] [Abstract][Full Text] [Related]
9. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
[TBL] [Abstract][Full Text] [Related]
10. Exploring biogenic chalcones as DprE1 inhibitors for antitubercular activity via in silico approach.
Rathod S; Chavan P; Mahuli D; Rochlani S; Shinde S; Pawar S; Choudhari P; Dhavale R; Mudalkar P; Tamboli F
J Mol Model; 2023 Mar; 29(4):113. PubMed ID: 36971900
[TBL] [Abstract][Full Text] [Related]
11. Discovery of newer pyrazole derivatives with potential anti-tubercular activity via 3D-QSAR based pharmacophore modelling, virtual screening, molecular docking and molecular dynamics simulation studies.
Modi P; Patel S; Chhabria M
Mol Divers; 2023 Aug; 27(4):1547-1566. PubMed ID: 35969333
[TBL] [Abstract][Full Text] [Related]
12. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
Chaudhari HK; Pahelkar A
Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
[TBL] [Abstract][Full Text] [Related]
13. Synthetic molecules as DprE1 inhibitors: A patent review.
Imran M; A S A; Thabet HK; Abida ; Afroz Bakht M
Expert Opin Ther Pat; 2021 Aug; 31(8):759-772. PubMed ID: 33709862
[TBL] [Abstract][Full Text] [Related]
14. Novel indolinone-tethered benzothiophenes as anti-tubercular agents against MDR/XDR M. tuberculosis: Design, synthesis, biological evaluation and in vivo pharmacokinetic study.
Eldehna WM; Mahmoud ST; Elshnawey ER; Elsayed ZM; Majrashi TA; El-Ashrey MK; Rashed M; Hemeda LR; Shoun AA; Elkaeed EB; El Hassab MA; Abdel-Aziz MM; Shahin MI
Bioorg Chem; 2024 Feb; 143():107009. PubMed ID: 38070474
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents.
Liu L; Kong C; Fumagalli M; Savková K; Xu Y; Huszár S; Sammartino JC; Fan D; Chiarelli LR; Mikušová K; Sun Z; Qiao C
Eur J Med Chem; 2020 Dec; 208():112773. PubMed ID: 32898793
[TBL] [Abstract][Full Text] [Related]
16. Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.
Venugopala KN; Chandrashekharappa S; Pillay M; Abdallah HH; Mahomoodally FM; Bhandary S; Chopra D; Attimarad M; Aldhubiab BE; Nair AB; Sreeharsha N; Morsy MA; Pottathil S; Venugopala R; Odhav B; Mlisana K
PLoS One; 2019; 14(6):e0217270. PubMed ID: 31163040
[TBL] [Abstract][Full Text] [Related]
17. Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of
Kouman KC; Keita M; Kre N'Guessan R; Owono Owono LC; Megnassan E; Frecer V; Miertus S
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554227
[TBL] [Abstract][Full Text] [Related]
18. Identification of some novel pyrazolo[1,5-a]pyrimidine derivatives as InhA inhibitors through pharmacophore-based virtual screening and molecular docking.
Modi P; Patel S; Chhabria MT
J Biomol Struct Dyn; 2019 Apr; 37(7):1736-1749. PubMed ID: 29663870
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor binding studies of
Mallavarapu BD; Abdullah M; Saxena S; Guruprasad L
J Biomol Struct Dyn; 2019 Sep; 37(14):3751-3763. PubMed ID: 30239262
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening and free energy estimation for identifying Mycobacterium tuberculosis flavoenzyme DprE1 inhibitors.
Niranjan Kumar ; Srivastava R; Prakash A; Lynn AM
J Mol Graph Model; 2021 Jan; 102():107770. PubMed ID: 33065513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
